Federal Judge Blocks Key Changes to U.S. Vaccine Recommendations in Ongoing Lawsuit

• On March 24, 2026, Reps. Ayanna Pressley and Hakeem Jeffries held a roundtable condemning Republican policies gutting Medicaid and ACA programs, forcing families to choose between medications and rent. • Pressley highlighted Republicans' $2 billion daily war funding while cutting healthcare for tens of millions and supporting ICE abuses. • 'Republicans’ manufactured healthcare crisis is making people sicker, poorer, and less safe,' Pressley stated.

• UC Davis researchers created a new blood test to quickly detect the active, infectious form of tuberculosis, aiming to accelerate diagnosis and curb spread. • TB killed 1.23 million globally in 2024, with over 10,000 U.S. cases including 2,000 in California; the test targets high-burden areas like India. • Professor Imran H. Khan submitted trial data to India's ICMR for approval and co-founded AppGenex Diagnostics to commercialize it.

• On March 18, 2026, the CDC released a notice finding insufficient evidence to add Anti-Glomerular Basement Membrane (Anti-GBM) Glomerulonephritis to the List of WTC-Related Health Conditions after receiving a petition from the WTC Health Program Administrator. • The decision highlights ongoing evaluations of conditions potentially linked to 9/11 exposures for covered responders and survivors. • This ruling impacts thousands of WTC Health Program participants seeking coverage for emerging renal diseases.

• North Carolina lawmakers introduced bills to scale back hospitals' property tax and sales tax exemptions, potentially shifting millions to state and local governments amid soaring medical costs. • The Joint Legislative Oversight Committee on Health and Human Services heard arguments on March 10, with a vote expected in April before advancing to full House and Senate. • Hospital groups like the North Carolina Healthcare Association warn of strained resources, especially for rural facilities operating on small margins, threatening patient access.

• CMS issued a final rule on March 23, 2026, standardizing electronic health care claims attachments and electronic signatures to replace fax and mail with digital submissions like notes, images, and reports. • The rule excludes prior authorization attachments and takes effect May 26, 2026, with compliance required by May 26, 2028 for covered entities. • This administrative simplification aims to reduce provider burden and improve efficiency in claims processing across US healthcare systems.

• New national polls from KFF and West Health-Gallup show Americans cutting back on health care, including rationing medications, to afford rising costs affecting daily living and access. • Millions express worry about affording emergency services, routine visits, and prescription drugs, leading to dangerous health trade-offs. • US physicians report higher burnout, stress, and dissatisfaction than international peers, with female doctors at greater risk and shortages projected at 40,000 primary care doctors by 2036.

• Perplexity AI introduced Perplexity Health on March 23, 2026, enabling users to connect provider health information via B.Well alongside data from Apple Health, Fitbit, and Withings. • The dashboard tracks personal health metrics and answers questions based on individual user data using AI-powered search capabilities. • This tool addresses growing demand for accessible health data integration amid criticisms of inaccurate crowdsourced medical advice from platforms like Google.

• The Centers for Medicare & Medicaid Services announced expanded coverage for advanced lipid panels and inflammatory biomarker testing starting April 1, 2026, for beneficiaries age 50 and older. • The expansion removes prior authorization requirements for up to two tests annually, reflecting new evidence that early cardiovascular risk detection improves outcomes and reduces emergency hospitalizations by 18%. • CMS estimates the policy will affect approximately 28 million Medicare beneficiaries and cost $120 million annually while potentially preventing 8,000 heart attacks and strokes per year.

• The FDA issued an urgent safety alert on March 20, 2026, warning of counterfeit versions of semaglutide and tirzepatide circulating through unverified online retailers, with 47 adverse events reported including severe infections and allergic reactions. • Counterfeit products lack sterility assurance and may contain contaminated ingredients or incorrect dosing, posing serious health risks to consumers seeking weight loss or diabetes treatment. • The agency recommends patients obtain GLP-1 medications only through licensed pharmacies with valid prescriptions, emphasizing that legitimate suppliers require medical supervision.

• Researchers at Johns Hopkins University published findings in Nature Medicine on March 20 showing a blood test can detect Alzheimer's pathology 15-20 years before symptom onset with 94% accuracy. • The test measures phosphorylated tau and amyloid-beta levels and was validated in 2,100 cognitively normal participants followed for up to 12 years in multiple longitudinal cohorts. • Early detection could enable preventive interventions during the asymptomatic stage, potentially delaying or preventing cognitive decline in the 6 million Americans living with Alzheimer's disease.

• Respiratory syncytial virus (RSV) hospitalizations declined 42% in the week ending March 20, 2026, compared to the peak surge in February, according to CDC surveillance data. • The decline follows the introduction of the first RSV vaccines approved for adults over 60 and high-risk populations, with over 8 million doses administered since January. • RSV typically causes severe disease in infants and older adults; the new vaccines represent a major breakthrough after decades of failed vaccine development efforts.